Work

Prolyl-tRNA synthetase inhibitor as a novel first-in-class keloid treatment: downregulation of de novo collagen synthesis and inflammatory cascade

Year: 2025

Type: article

Source: British Journal of Dermatology

DOI: 10.1093/bjd/ljaf140

Authors: Sally Min, Ki-Myo Kim, Joseph Hwang, Jaewoo Kim, Jun Ho Park, Jun Ho Park, Joon Seok Park, Joon Seok Park, Caroline H Lee, Ji-Ung Park, Ji-Ung Park

Institutions: Seoul National University, SNUH SMG-SNU Boramae Medical Center, Daewoong Pharmaceutical (South Korea)

Language: English

Topic: Dermatologic Treatments and Research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Research Foundation of Korea, Daewoong Pharmaceutical Company

Award: G8983590423

OpenAlex ID: W4409449048

FWCI: 3.188

Cites: 37

Cited by: 4

Related to: 10